Author

Chiaki Inagaki

Observed names: 稲垣, 千晶, 稲垣千晶

OpenAlex ID: A5152473571

Plasmatic biomarkers of BRAF inhibitor combination therapy for BRAF-mutated metastatic colorectal cancer: Insights from the BEETS trial (JACCRO CC-18)

· Chiaki Inagaki, Ryo Matoba, et al. · Institutional Repositories DataBase (IRDB)

Comprehensive biomarker study of zolbetuximab plus CapeOX or SOX to identify predictors of efficacy and resistance mechanisms in patients with HER2-negative, CLDN18.2-positive gastric or gastro-oesophageal junction cancer (JACCRO GC-12AR)

· Yohei Kubota, Genki Usui, et al. · Institutional Repositories DataBase (IRDB)

ニボルマブ単剤治療を受けた胃がん患者における血中cell-free DNAの治療効果予測における臨床的有用性の検討

· 稲垣, 千晶 · Institutional Repositories DataBase (IRDB)

通過障害合併Stage IVB食道癌における免疫チェックポイント阻害薬併用化学療法の実用的第2相試験

· 永田祐介, 新井裕之, et al. · Institutional Repositories DataBase (IRDB)

An Observational Study of BRAF Inhibitor Combination Therapy for BRAF-mutated Metastatic Colorectal Cancer Patients: Real-World Evidence from BEETS Trial (JACCRO CC-18)

· 稲垣千晶, 傳田忠道, et al. · Institutional Repositories DataBase (IRDB)

Encorafenib and cetuximab with/without binimetinib therapies for patients with BRAF-mutated metastatic colorectal cancer with prognostic factors: The BEETS trial (JACCRO CC-18).

· Yu Sunakawa, Eisuke Inoue, et al. · Institutional Repositories DataBase (IRDB)

PROCEED試験(CyberOncology®)でのCyberOncology®の利便性に関するアンケート調査

· 古田光寛, 岡本渉, et al. · Institutional Repositories DataBase (IRDB)

胃癌患者におけるニボルマブの新規予後予測バイオマーカーとしての血中OXPHOS 関連遺伝子シグネチャーとSNPs

· 稲垣千晶, 的場亮, et al. · Institutional Repositories DataBase (IRDB)

Works count: 8

Citation count:

H-index:

I10-index: